Solstice Oncology
PrivateLast Round
Series A
Sep 9, 2026
Total Funding Raised
$225M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Solstice Oncology is a clinical-stage immuno-oncology company that develops therapeutic treatments for cancer in the neoadjuvant setting.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Solstice Oncology Comparables
Compare Solstice Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OncoC4, Inc. | 78% | |
| Evida Biosciences | 77% | |
| Brenus Pharma | 77% |
Solstice Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 9, 2026 |
Solstice Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A |
| Forbion | Series A |
| Canaan Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 9, 2026
$225M round led by RA Capital Management.
Recent news
Latest coverage and updates
- receives_financingSep 9, 2026
Solstice Oncology received financing of $225M in Series A on Sep 9th '26.
Solstice Oncology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Solstice Oncology's valuation, stock price, and market status.
Is Solstice Oncology a public or private company?
Solstice Oncology is a private company.
What is the current stock price of Solstice Oncology?
Solstice Oncology is a private company with no public stock price. Caplight tracks Solstice Oncology's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Solstice Oncology worth (valuation)?
Valuation information for Solstice Oncology is not publicly available.
Can I buy Solstice Oncology stock?
Solstice Oncology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Solstice Oncology's last funding round?
Solstice Oncology's most recent funding round was Series A on September 9, 2026.
Who are the main investors in Solstice Oncology?
Key investors in Solstice Oncology include RA Capital Management.
Will Solstice Oncology IPO soon?
No public IPO plans have been announced for Solstice Oncology.
How can I track Solstice Oncology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Solstice Oncology's secondary market activity and sign up for updates.